Combination therapy for treating drug-resistance cancer using Rifabutin

The present invention relates to an anticancer adjuvant containing rifabutin as an active ingredient, which is a novel anticancer adjuvant which can be administered in combination with anticancer drugs to resistant cancer cells overexpressing P-glycoprotein (P-gp), which can excrete an anticancer ag...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: YOON SUNGPIL, KIM HYUNG SIK, LEE BYUNG MU, PARK JAE HYEON, LEE JI SUN, PARK JI WON, OH YUNMOON
Format: Patent
Sprache:eng ; kor
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!